Company / EPS (Basic)
LEXICON PHARMACEUTICALS, INC. EPS (Basic) History
FY2015-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Basic)
-$0.80
FY2025
5-year range
-$0.80 / -$0.53
FY2021-FY2025
Trend
-29.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
EPS (Basic) has declined for 4 consecutive years, from $-0.27 in FY2015 to $-0.80 in FY2025.
Based on SEC 10-K filings.
-0.80 in FY2025.
Declined from $-0.60 to $-0.80 over the past 2 years.
EPS (Basic) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- LEXICON PHARMACEUTICALS, INC.'s eps (basic) has declined for 3 consecutive years.
- In FY2025, eps (basic) decreased 29.0% year-over-year.
- Peak eps (basic) was recorded in FY2015.
Company context
Key Data Points
- Altman Z-Score -1.98 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Basic)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$0.80 | -29.0% |
| FY2024 | -$0.62 | -3.3% |
| FY2023 | -$0.60 | -13.2% |
| FY2019 | -$0.53 | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
| FY2015 | -$0.27 | - |
| FY2014 | - | - |
| FY2013 | - | - |
As of FY2025 · SEC 10-K Annual Filings · Updated Jun 24, 2026